B
Medpace Holdings, Inc.
MEDP
$332.81
$7.082.17%
B
Buy
3/3/2025Upgraded
Medpace Holdings, Inc. (MEDP) was upgraded to B- from C+ on 3/3/2025 due to an increase in the valuation index, growth index and total return index. Operating cash flow increased 27.9% from $149.08M to $190.67M, earnings per share increased from $3.01 to $3.6733, and EBIT increased 11.67% from $112.27M to $125.38M.
Medpace Holdings, Inc. (MEDP) was upgraded to B- from C+ on 3/3/2025 due to an increase in the valuation index, growth index and total return index. Operating cash flow increased 27.9% from $149.08M to $190.67M, earnings per share increased from $3.01 to $3.6733, and EBIT increased 11.67% from $112.27M to $125.38M.
C
Hold
9/25/2024Downgrade
Medpace Holdings, Inc. (MEDP) was downgraded to C+ from B- on 9/25/2024 due to a large decline in the total return index, growth index and volatility index. Operating cash flow declined 23.76% from $152.68M to $116.4M, and earnings per share declined from $3.2 to $2.75.
Medpace Holdings, Inc. (MEDP) was downgraded to C+ from B- on 9/25/2024 due to a large decline in the total return index, growth index and volatility index. Operating cash flow declined 23.76% from $152.68M to $116.4M, and earnings per share declined from $3.2 to $2.75.
B
Buy
7/11/2024Downgrade
Medpace Holdings, Inc. (MEDP) was downgraded to B- from B on 7/11/2024 due to a noticeable decline in the total return index, growth index and efficiency index. Operating cash flow declined 2.38% from $156.4M to $152.68M.
Medpace Holdings, Inc. (MEDP) was downgraded to B- from B on 7/11/2024 due to a noticeable decline in the total return index, growth index and efficiency index. Operating cash flow declined 2.38% from $156.4M to $152.68M.
B
Buy
3/11/2024Upgraded
Medpace Holdings, Inc. (MEDP) was upgraded to B from B- on 3/11/2024 due to a noticeable increase in the total return index and volatility index.
Medpace Holdings, Inc. (MEDP) was upgraded to B from B- on 3/11/2024 due to a noticeable increase in the total return index and volatility index.
B
Buy
2/23/2024Downgrade
Medpace Holdings, Inc. (MEDP) was downgraded to B- from B on 2/23/2024 due to a decline in the total return index, valuation index and growth index.
Medpace Holdings, Inc. (MEDP) was downgraded to B- from B on 2/23/2024 due to a decline in the total return index, valuation index and growth index.
B
Buy
2/13/2024Upgraded
Medpace Holdings, Inc. (MEDP) was upgraded to B from B- on 2/13/2024 due to a large increase in the total return index and volatility index.
Medpace Holdings, Inc. (MEDP) was upgraded to B from B- on 2/13/2024 due to a large increase in the total return index and volatility index.
B
Buy
1/29/2024Downgrade
Medpace Holdings, Inc. (MEDP) was downgraded to B- from B on 1/29/2024 due to a large decline in the total return index and valuation index.
Medpace Holdings, Inc. (MEDP) was downgraded to B- from B on 1/29/2024 due to a large decline in the total return index and valuation index.
B
Buy
11/3/2023Upgraded
Medpace Holdings, Inc. (MEDP) was upgraded to B from B- on 11/3/2023 due to an increase in the total return index, growth index and efficiency index. Operating cash flow increased 38.62% from $82.52M to $114.39M, net income increased 15.53% from $61.07M to $70.55M, and earnings per share increased from $1.93 to $2.22.
Medpace Holdings, Inc. (MEDP) was upgraded to B from B- on 11/3/2023 due to an increase in the total return index, growth index and efficiency index. Operating cash flow increased 38.62% from $82.52M to $114.39M, net income increased 15.53% from $61.07M to $70.55M, and earnings per share increased from $1.93 to $2.22.
B
Buy
10/23/2023Downgrade
Medpace Holdings, Inc. (MEDP) was downgraded to B- from B on 10/23/2023 due to a decline in the total return index.
Medpace Holdings, Inc. (MEDP) was downgraded to B- from B on 10/23/2023 due to a decline in the total return index.
B
Buy
10/6/2023Upgraded
Medpace Holdings, Inc. (MEDP) was upgraded to B from B- on 10/6/2023 due to an increase in the valuation index and total return index.
Medpace Holdings, Inc. (MEDP) was upgraded to B from B- on 10/6/2023 due to an increase in the valuation index and total return index.
B
Buy
9/21/2023Downgrade
Medpace Holdings, Inc. (MEDP) was downgraded to B- from B on 9/21/2023 due to a decline in the valuation index and total return index.
Medpace Holdings, Inc. (MEDP) was downgraded to B- from B on 9/21/2023 due to a decline in the valuation index and total return index.
B
Buy
8/10/2023Upgraded
Medpace Holdings, Inc. (MEDP) was upgraded to B from B- on 8/10/2023 due to a noticeable increase in the total return index and growth index.
Medpace Holdings, Inc. (MEDP) was upgraded to B from B- on 8/10/2023 due to a noticeable increase in the total return index and growth index.
B
Buy
7/26/2023Downgrade
Medpace Holdings, Inc. (MEDP) was downgraded to B- from B on 7/26/2023 due to a noticeable decline in the total return index and growth index. Earnings per share declined from $2.27 to $1.93, and EBIT declined 9.06% from $86.2M to $78.39M.
Medpace Holdings, Inc. (MEDP) was downgraded to B- from B on 7/26/2023 due to a noticeable decline in the total return index and growth index. Earnings per share declined from $2.27 to $1.93, and EBIT declined 9.06% from $86.2M to $78.39M.
B
Buy
7/24/2023Upgraded
Medpace Holdings, Inc. (MEDP) was upgraded to B from B- on 7/24/2023 due to a large increase in the total return index.
Medpace Holdings, Inc. (MEDP) was upgraded to B from B- on 7/24/2023 due to a large increase in the total return index.
B
Buy
7/5/2023Upgraded
Medpace Holdings, Inc. (MEDP) was upgraded to B- from C+ on 7/5/2023 due to an increase in the total return index.
Medpace Holdings, Inc. (MEDP) was upgraded to B- from C+ on 7/5/2023 due to an increase in the total return index.
C
Hold
5/18/2023Downgrade
Medpace Holdings, Inc. (MEDP) was downgraded to C+ from B- on 5/18/2023 due to a major decline in the total return index and growth index. Operating cash flow declined 41.42% from $136.68M to $80.08M.
Medpace Holdings, Inc. (MEDP) was downgraded to C+ from B- on 5/18/2023 due to a major decline in the total return index and growth index. Operating cash flow declined 41.42% from $136.68M to $80.08M.
B
Buy
2/27/2023Downgrade
Medpace Holdings, Inc. (MEDP) was downgraded to B- from B on 2/27/2023 due to a noticeable decline in the total return index and growth index. EBIT declined 1.79% from $77.83M to $76.43M.
Medpace Holdings, Inc. (MEDP) was downgraded to B- from B on 2/27/2023 due to a noticeable decline in the total return index and growth index. EBIT declined 1.79% from $77.83M to $76.43M.
B
Buy
1/19/2023Upgraded
Medpace Holdings, Inc. (MEDP) was upgraded to B from B- on 1/19/2023 due to a significant increase in the total return index and volatility index.
Medpace Holdings, Inc. (MEDP) was upgraded to B from B- on 1/19/2023 due to a significant increase in the total return index and volatility index.
B
Buy
1/6/2023Upgraded
Medpace Holdings, Inc. (MEDP) was upgraded to B- from C+ on 1/6/2023 due to an increase in the growth index, total return index and valuation index. Earnings per share increased from $1.46 to $2.05, EBIT increased 29.2% from $60.24M to $77.83M, and operating cash flow increased 12.29% from $96.62M to $108.49M.
Medpace Holdings, Inc. (MEDP) was upgraded to B- from C+ on 1/6/2023 due to an increase in the growth index, total return index and valuation index. Earnings per share increased from $1.46 to $2.05, EBIT increased 29.2% from $60.24M to $77.83M, and operating cash flow increased 12.29% from $96.62M to $108.49M.
C
Hold
4/21/2022Downgrade
Medpace Holdings, Inc. (MEDP) was downgraded to C+ from B- on 4/21/2022 due to a large decline in the solvency index, volatility index and valuation index.
Medpace Holdings, Inc. (MEDP) was downgraded to C+ from B- on 4/21/2022 due to a large decline in the solvency index, volatility index and valuation index.
B
Buy
2/23/2022Downgrade
Medpace Holdings, Inc. (MEDP) was downgraded to B- from B on 2/23/2022 due to a significant decline in the total return index, volatility index and growth index. Operating cash flow declined 2.02% from $72.35M to $70.89M.
Medpace Holdings, Inc. (MEDP) was downgraded to B- from B on 2/23/2022 due to a significant decline in the total return index, volatility index and growth index. Operating cash flow declined 2.02% from $72.35M to $70.89M.
B
Buy
1/10/2022Downgrade
Medpace Holdings, Inc. (MEDP) was downgraded to B from B+ on 1/10/2022 due to a decline in the total return index.
Medpace Holdings, Inc. (MEDP) was downgraded to B from B+ on 1/10/2022 due to a decline in the total return index.
B
Buy
11/3/2021Upgraded
Medpace Holdings, Inc. (MEDP) was upgraded to B+ from B on 11/3/2021 due to an increase in the total return index, growth index and solvency index. EBIT increased 26.54% from $42.45M to $53.71M, earnings per share increased from $1.06 to $1.29, and operating cash flow increased 15.28% from $62.76M to $72.35M.
Medpace Holdings, Inc. (MEDP) was upgraded to B+ from B on 11/3/2021 due to an increase in the total return index, growth index and solvency index. EBIT increased 26.54% from $42.45M to $53.71M, earnings per share increased from $1.06 to $1.29, and operating cash flow increased 15.28% from $62.76M to $72.35M.
B
Buy
10/22/2021Downgrade
Medpace Holdings, Inc. (MEDP) was downgraded to B from B+ on 10/22/2021 due to a noticeable decline in the total return index.
Medpace Holdings, Inc. (MEDP) was downgraded to B from B+ on 10/22/2021 due to a noticeable decline in the total return index.
B
Buy
10/7/2021Upgraded
Medpace Holdings, Inc. (MEDP) was upgraded to B+ from B on 10/7/2021 due to a large increase in the total return index.
Medpace Holdings, Inc. (MEDP) was upgraded to B+ from B on 10/7/2021 due to a large increase in the total return index.
B
Buy
9/20/2021Downgrade
Medpace Holdings, Inc. (MEDP) was downgraded to B from B+ on 9/20/2021 due to a major decline in the total return index and valuation index.
Medpace Holdings, Inc. (MEDP) was downgraded to B from B+ on 9/20/2021 due to a major decline in the total return index and valuation index.
B
Buy
9/3/2021Upgraded
Medpace Holdings, Inc. (MEDP) was upgraded to B+ from B on 9/3/2021 due to a large increase in the total return index.
Medpace Holdings, Inc. (MEDP) was upgraded to B+ from B on 9/3/2021 due to a large increase in the total return index.
B
Buy
8/19/2021Downgrade
Medpace Holdings, Inc. (MEDP) was downgraded to B from B+ on 8/19/2021 due to a noticeable decline in the total return index.
Medpace Holdings, Inc. (MEDP) was downgraded to B from B+ on 8/19/2021 due to a noticeable decline in the total return index.
B
Buy
8/4/2021Upgraded
Medpace Holdings, Inc. (MEDP) was upgraded to B+ from B on 8/4/2021 due to an increase in the growth index, valuation index and solvency index. Operating cash flow increased 9.49% from $57.32M to $62.76M, and total revenue increased 7.05% from $259.97M to $278.29M.
Medpace Holdings, Inc. (MEDP) was upgraded to B+ from B on 8/4/2021 due to an increase in the growth index, valuation index and solvency index. Operating cash flow increased 9.49% from $57.32M to $62.76M, and total revenue increased 7.05% from $259.97M to $278.29M.
B
Buy
6/28/2021Downgrade
Medpace Holdings, Inc. (MEDP) was downgraded to B from B+ on 6/28/2021 due to a decline in the valuation index and volatility index.
Medpace Holdings, Inc. (MEDP) was downgraded to B from B+ on 6/28/2021 due to a decline in the valuation index and volatility index.
B
Buy
6/11/2021Upgraded
Medpace Holdings, Inc. (MEDP) was upgraded to B+ from B on 6/11/2021 due to a large increase in the total return index.
Medpace Holdings, Inc. (MEDP) was upgraded to B+ from B on 6/11/2021 due to a large increase in the total return index.
B
Buy
5/25/2021Downgrade
Medpace Holdings, Inc. (MEDP) was downgraded to B from B+ on 5/25/2021 due to a noticeable decline in the total return index.
Medpace Holdings, Inc. (MEDP) was downgraded to B from B+ on 5/25/2021 due to a noticeable decline in the total return index.
B
Buy
5/10/2021Upgraded
Medpace Holdings, Inc. (MEDP) was upgraded to B+ from B on 5/10/2021 due to a large increase in the total return index, valuation index and volatility index.
Medpace Holdings, Inc. (MEDP) was upgraded to B+ from B on 5/10/2021 due to a large increase in the total return index, valuation index and volatility index.
B
Buy
4/27/2021Downgrade
Medpace Holdings, Inc. (MEDP) was downgraded to B from B+ on 4/27/2021 due to a decline in the total return index and valuation index.
Medpace Holdings, Inc. (MEDP) was downgraded to B from B+ on 4/27/2021 due to a decline in the total return index and valuation index.
B
Buy
4/12/2021Upgraded
Medpace Holdings, Inc. (MEDP) was upgraded to B+ from B on 4/12/2021 due to a noticeable increase in the total return index and volatility index.
Medpace Holdings, Inc. (MEDP) was upgraded to B+ from B on 4/12/2021 due to a noticeable increase in the total return index and volatility index.
B
Buy
3/25/2021Downgrade
Medpace Holdings, Inc. (MEDP) was downgraded to B from B+ on 3/25/2021 due to a decline in the total return index, volatility index and valuation index.
Medpace Holdings, Inc. (MEDP) was downgraded to B from B+ on 3/25/2021 due to a decline in the total return index, volatility index and valuation index.
B
Buy
3/10/2021Upgraded
Medpace Holdings, Inc. (MEDP) was upgraded to B+ from B on 3/10/2021 due to a noticeable increase in the growth index, solvency index and total return index. Operating cash flow increased 76.53% from $59.76M to $105.5M, earnings per share increased from $1.09 to $1.3416, and EBIT increased 18.45% from $46.42M to $54.99M.
Medpace Holdings, Inc. (MEDP) was upgraded to B+ from B on 3/10/2021 due to a noticeable increase in the growth index, solvency index and total return index. Operating cash flow increased 76.53% from $59.76M to $105.5M, earnings per share increased from $1.09 to $1.3416, and EBIT increased 18.45% from $46.42M to $54.99M.
B
Buy
9/29/2020Upgraded
Medpace Holdings, Inc. (MEDP) was upgraded to B from B- on 9/29/2020 due to a large increase in the total return index and valuation index.
Medpace Holdings, Inc. (MEDP) was upgraded to B from B- on 9/29/2020 due to a large increase in the total return index and valuation index.
B
Buy
9/14/2020Downgrade
Medpace Holdings, Inc. (MEDP) was downgraded to B- from B on 9/14/2020 due to a large decline in the total return index.
Medpace Holdings, Inc. (MEDP) was downgraded to B- from B on 9/14/2020 due to a large decline in the total return index.
B
Buy
8/24/2020Upgraded
Medpace Holdings, Inc. (MEDP) was upgraded to B from B- on 8/24/2020 due to a large increase in the total return index.
Medpace Holdings, Inc. (MEDP) was upgraded to B from B- on 8/24/2020 due to a large increase in the total return index.
B
Buy
8/7/2020Downgrade
Medpace Holdings, Inc. (MEDP) was downgraded to B- from B on 8/7/2020 due to a large decline in the total return index and valuation index.
Medpace Holdings, Inc. (MEDP) was downgraded to B- from B on 8/7/2020 due to a large decline in the total return index and valuation index.
B
Buy
2/25/2020Upgraded
Medpace Holdings, Inc. (MEDP) was upgraded to B from B- on 2/25/2020 due to a large increase in the total return index, volatility index and efficiency index.
Medpace Holdings, Inc. (MEDP) was upgraded to B from B- on 2/25/2020 due to a large increase in the total return index, volatility index and efficiency index.
B
Buy
1/2/2020Downgrade
Medpace Holdings, Inc. (MEDP) was downgraded to B- from B on 1/2/2020 due to a decline in the valuation index and volatility index.
Medpace Holdings, Inc. (MEDP) was downgraded to B- from B on 1/2/2020 due to a decline in the valuation index and volatility index.
B
Buy
7/30/2019Upgraded
Medpace Holdings, Inc. (MEDP) was upgraded to B from B- on 7/30/2019 due to an increase in the total return index.
Medpace Holdings, Inc. (MEDP) was upgraded to B from B- on 7/30/2019 due to an increase in the total return index.
B
Buy
5/30/2019Downgrade
Medpace Holdings, Inc. (MEDP) was downgraded to B- from B on 5/30/2019 due to a noticeable decline in the growth index. Earnings per share declined from $0.6096 to $0.51, EBIT declined 15.56% from $30.67M to $25.9M, and operating cash flow declined 13.78% from $39.44M to $34.01M.
Medpace Holdings, Inc. (MEDP) was downgraded to B- from B on 5/30/2019 due to a noticeable decline in the growth index. Earnings per share declined from $0.6096 to $0.51, EBIT declined 15.56% from $30.67M to $25.9M, and operating cash flow declined 13.78% from $39.44M to $34.01M.
B
Buy
11/6/2018Upgraded
Medpace Holdings, Inc. (MEDP) was upgraded to B from B- on 11/6/2018 due to an increase in the total return index and volatility index.
Medpace Holdings, Inc. (MEDP) was upgraded to B from B- on 11/6/2018 due to an increase in the total return index and volatility index.
B
Buy
11/1/2018Upgraded
Medpace Holdings, Inc. (MEDP) was upgraded to B- from C+ on 11/1/2018 due to a major increase in the growth index, efficiency index and solvency index. Debt to equity declined from 0.31 to 0.21, operating cash flow increased 26.99% from $41.34M to $52.5M, and net income increased 16.52% from $16.57M to $19.31M.
Medpace Holdings, Inc. (MEDP) was upgraded to B- from C+ on 11/1/2018 due to a major increase in the growth index, efficiency index and solvency index. Debt to equity declined from 0.31 to 0.21, operating cash flow increased 26.99% from $41.34M to $52.5M, and net income increased 16.52% from $16.57M to $19.31M.
C
Hold
3/20/2018Upgraded
Medpace Holdings, Inc. (MEDP) was upgraded to C+ from C on 3/20/2018 due to an increase in the total return index and volatility index.
Medpace Holdings, Inc. (MEDP) was upgraded to C+ from C on 3/20/2018 due to an increase in the total return index and volatility index.
C
Hold
3/5/2018Downgrade
Medpace Holdings, Inc. (MEDP) was downgraded to C from C+ on 3/5/2018 due to a noticeable decline in the growth index, total return index and solvency index. Debt to equity increased from 0.34 to 0.44, operating cash flow declined 26.53% from $39M to $28.65M, and EBIT declined 10.24% from $17.2M to $15.44M.
Medpace Holdings, Inc. (MEDP) was downgraded to C from C+ on 3/5/2018 due to a noticeable decline in the growth index, total return index and solvency index. Debt to equity increased from 0.34 to 0.44, operating cash flow declined 26.53% from $39M to $28.65M, and EBIT declined 10.24% from $17.2M to $15.44M.
C
Hold
11/6/2017Upgraded
Medpace Holdings, Inc. (MEDP) was upgraded to C+ from C on 11/6/2017 due to a noticeable increase in the total return index and volatility index.
Medpace Holdings, Inc. (MEDP) was upgraded to C+ from C on 11/6/2017 due to a noticeable increase in the total return index and volatility index.
C
Hold
11/2/2017Upgraded
Medpace Holdings, Inc. (MEDP) was upgraded to C from C- on 11/2/2017 due to a significant increase in the growth index, total return index and valuation index. Operating cash flow increased 28.26% from $30.41M to $39M, earnings per share increased from $0.23 to $0.25, and EBIT increased 5.65% from $16.28M to $17.2M.
Medpace Holdings, Inc. (MEDP) was upgraded to C from C- on 11/2/2017 due to a significant increase in the growth index, total return index and valuation index. Operating cash flow increased 28.26% from $30.41M to $39M, earnings per share increased from $0.23 to $0.25, and EBIT increased 5.65% from $16.28M to $17.2M.
C
Hold
8/3/2017Upgraded
Medpace Holdings, Inc. (MEDP) was upgraded to C- from D+ on 8/3/2017 due to an increase in the efficiency index, growth index and volatility index. Operating cash flow increased 4,604.89% from -$675 to $30.41M, earnings per share increased from $0.2 to $0.23, and net income increased 13.09% from $8.45M to $9.55M.
Medpace Holdings, Inc. (MEDP) was upgraded to C- from D+ on 8/3/2017 due to an increase in the efficiency index, growth index and volatility index. Operating cash flow increased 4,604.89% from -$675 to $30.41M, earnings per share increased from $0.2 to $0.23, and net income increased 13.09% from $8.45M to $9.55M.
D
Sell
5/12/2017Downgrade
Medpace Holdings, Inc. (MEDP) was downgraded to D+ from C- on 5/12/2017 due to a large decline in the volatility index, growth index and total return index. Operating cash flow declined 102.28% from $29.57M to -$675, and total revenue declined 1.67% from $95.38M to $93.78M.
Medpace Holdings, Inc. (MEDP) was downgraded to D+ from C- on 5/12/2017 due to a large decline in the volatility index, growth index and total return index. Operating cash flow declined 102.28% from $29.57M to -$675, and total revenue declined 1.67% from $95.38M to $93.78M.
C
Hold
4/17/2017Downgrade
Medpace Holdings, Inc. (MEDP) was downgraded to C- from C on 4/17/2017 due to a significant decline in the volatility index, growth index and efficiency index. Net income declined 100.42% from $5.04M to -$21, earnings per share declined from $0.13 to -$0.0005, and operating cash flow declined 29.89% from $42.18M to $29.57M.
Medpace Holdings, Inc. (MEDP) was downgraded to C- from C on 4/17/2017 due to a significant decline in the volatility index, growth index and efficiency index. Net income declined 100.42% from $5.04M to -$21, earnings per share declined from $0.13 to -$0.0005, and operating cash flow declined 29.89% from $42.18M to $29.57M.
C
Hold
11/4/2016None
Medpace Holdings, Inc. (MEDP) was downgraded to C from U on 11/04/2016.
Medpace Holdings, Inc. (MEDP) was downgraded to C from U on 11/04/2016.
NASDAQ
03/07/2025 3:00PM Eastern
Quotes delayed
